Goldman Sachs Initiates Coverage On Versigent with Buy Rating, Announces Price Target of $48

Versigent PLC

Versigent PLC

VGNT

0.00

Goldman Sachs analyst Mark Delaney initiates coverage on Versigent (NYSE: VGNT) with a Buy rating and announces Price Target of $48.